Vol. 27.Issue. 6. November - December 2022 | Annals of Hepatology

¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta

* = Required fields

Enter your email address

User name *

Annals of Hepatology

Buscar en

Annals of Hepatology

Toda la web

Inicio Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more

Impact factor 2022

3.8

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2022

6.3

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2022

0.859

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2022

0.989

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 27. Issue 6.

(November - December 2022)

Editorial board

Ann Hepatol. 2022;27:100778

Full text access

Editorials

The importance of bile Acids in NAFLD: current evidence and future directions

Alvaro Rivera-Andrade, Christian S. Álvarez

Ann Hepatol. 2022;27:100773

Full text access

Opinions

Nationwide marketing as a tool to increase literacy and awareness for living liver donation

Stela Celaj, Swaytha Ganesh, Christopher B. Hughes, Jessica Weidensall, Christine Caruso, Abhinav Humar, Andres Duarte-Rojo

Ann Hepatol. 2022;27:100768

Full text access

Concise reviews

Current approaches to hepatic encephalopathy

Paulina Vidal-Cevallos, Norberto C. Chávez-Tapia, Misael Uribe

Ann Hepatol. 2022;27:100757

Full text access

Original articles

Randomised controlled trial: effect of metformin add-on therapy on functional cure in entecavir-treated patients with chronic hepatitis B

Wei Zhang, Yuan-Yuan Li, Qing-Hua Shang, Lin Qi, Mi-Mi Sun, Gang Chen, Yong An, Jing-Xin Li, ... Fu-Sheng Wang

Ann Hepatol. 2022;27:100745

Full text access

Safety and efficacy of dyslipidemia treatment in NAFLD patients: a meta-analysis of randomized controlled trials

Mohamed Abdallah, Landon Brown, John Provenza, Raseen Tariq, Smitha Gowda, Ashwani K. Singal

Ann Hepatol. 2022;27:100738

Full text access

Risk factors associated with HCV co-infection amongst MSM and transgender women living with HIV in Mexico City: a case-control study

Luis E. Ramirez-Gonzalez, Antonio Camiro-Zúñiga, Alicia Piñeirua- Menendez, Juan F. Sánchez-Avila, A. Harumi Hirata-Hernández, Karen A. Marañón-Solorio, Irwin Zamora-Tapia, Areli Pérez-Carrizosa, ... Juan G. Sierra-Madero

Ann Hepatol. 2022;27:100758

Full text access

Post-hepatectomy liver failure prediction and prevention: Development of a nomogram containing postoperative anticoagulants as a risk factor

Yi-Ran Li, Jin-Dong Chen, Jian Huang, Fei-xiang Wu, Guang-Zhi Jin

Ann Hepatol. 2022;27:100744

Full text access

Liver resection for single large hepatocellular carcinoma: a prognostic factors study

Vincent Nguyen-Khac, Raffaele Brustia, Rami Rhaiem, Hélène Regnault, Anna Sessa, Sebastien Mule, Christophe Duvoux, Alexis Laurent, ... Daniele Sommacale

Ann Hepatol. 2022;27:100739

Full text access

Outcomes of liver transplantation in patients 70 years or older: a systematic review and meta-analysis

Babu Pappu Mohan, Sentia Iriana, Shahab Rasool Khan, Pradeep Yarra, Suresh Ponnada, Juan Fernando Gallegos-Orozco

Ann Hepatol. 2022;27:100741

Full text access

Prevalence and impact of Sjögren's syndrome in primary biliary cholangitis: a systematic review and meta-analysis

Xiaoling Deng, Jiahuan Li, Shuhui Hou, Bai Ci, Beibei Liu, Keshu Xu

Ann Hepatol. 2022;27:100746

Full text access

Waitlist mortality in patients with autoimmune liver diseases

Daniela Goyes, Romelia Barba, Esli Medina-Morales, Behnam Saberi, Vilas Patwardhan, Alan Bonder

Ann Hepatol. 2022;27:100742

Full text access

Hepatic mir-122-3p, mir-140-5p and mir-148b-5p expressions are correlated with cytokeratin-18 serum levels in MAFLD

Guillermo N. López-Sánchez, Eduardo Montalvo-Javé, Mayra Domínguez-Perez, Barbara Antuna-Puente, Fredy O. Beltrán-Anaya, Alfredo Hidalgo-Miranda, Norberto C. Chávez-Tapia, Misael Uribe, Natalia Nuño- Lámbarri

Ann Hepatol. 2022;27:100756

Full text access

Circ_0008285 knockdown represses tumor development by miR-384/RRM2 axis in hepatocellular carcinoma

Shuang Peng, Lai Yi, Lingzhi Liao, Yuling Bin, Weiming Qu, Hongsai Hu

Ann Hepatol. 2022;27:100743

Full text access

An acknowledgement

An Acknowledgement

Ann Hepatol. 2022;27:100781

Full text access

Special issue on genomic medicine in obesity and chronic liver damage

NAFLD VS MAFLD. The evidence-based debate has come. Time to change?

Diego García-Compeán, Alan Rafael Jiménez-Rodríguez

Ann Hepatol. 2022;27:100765

Full text access

Non-alcoholic fatty liver disease prevalence in Latin America: A systematic review and meta-analysis

Yesmi A. Ortega Rojas, Claudia L. Vidal Cuellar, Karina M. Aparicio Barrón, Juan Pablo Arab, Adelina Lozano Miranda

Ann Hepatol. 2022;27:100706

Full text access

African genetic ancestry is associated with lower frequency of PNPLA3 G allele in non-alcoholic fatty liver in an admixed population

Lourianne Nascimento Cavalcante, Jun Porto, Daniel Mazo, Adhemar Longatto-Filho, José Tadeu Stefano, Andre Castro Lyra, Flair Jose Carrilho, Rui Manuel Reis, ... Claudia P Oliveira

Ann Hepatol. 2022;27:100728

Full text access

Whole-Exome Sequencing identified Olfactory Receptor genes as a key contributor to extreme obesity with progression to nonalcoholic steatohepatitis in Mexican patients

Luis Alberto Torres-Reyes, Karina Gonzalez-Aldaco, Arturo Panduro, Alexis Jose-Abrego, Sonia Roman

Ann Hepatol. 2022;27:100767

Full text access